Licensing Opportunities for Neglected Diseases Featured on OTT Web Site
Neglected diseases affect approximately 1 billion people, primarily in developing countries. However, since most R&D is not focused on neglected diseases, very few new treatments are brought to market.
Through its partnerships with international public and private institutions, the NIH Office of Technology Transfer (OTT) has identified a number of neglected diseases with crucial technology transfer needs. NIH, the Food and Drug Administration, and several U.S. university technology transfer offices have compiled a list of their technologies that relate to these specific neglected diseases. This list is expected to function as an additional tool to facilitate the transfer of such technologies to potential licensee institutions worldwide.
The listing of neglected diseases includes:
- African Trypanosomiasis (Sleeping Sickness)
- Dengue Fever
- General (Vaccines and Biotherapeutics)
- Hepatitis B
- HIV/AIDS
- Intestinal Parasites
- Leprosy
- Lymphatic Filariasis (Elephantiasis)
- Malaria
- Rotavirus
- Schistosomiasis
- Tuberculosis
- Visceral Leishmaniasis
Available technologies for these diseases, along with contact information, can be found on the OTT Web site.
OTT is also in the process of establishing a listing of available technologies that are applicable to rare diseases. An announcement will be made at the OTT Web site (www.ott.nih.gov) once this listing is available.